Soleno Therapeutics
Price & Volume
Stats
See more52W Range | $41.50-$90.31 |
Market Cap | $3.3B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $32.6M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $31.9M |
Diluted EPS | -$4.22 |
News
See moreYahoo Finance • yesterday
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Yahoo Finance • 2 days ago
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman
Yahoo Finance • 2 days ago
SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm
Yahoo Finance • 3 days ago
SLNO 投資者消息：若您因 Soleno Therapeutics, Inc. (NASDAQ: SLNO) 蒙受損失，請聯絡 Rosen Law Firm 了解您的權益
About
CEO | Dr. Anish Bhatnagar M.D. |
CFO | Mr. James H. MacKaness |
Address | 100 Marine Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 133 |
